Amsterdam Molecular Therapeutics Licenses Rights to IL-10
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 28 (Table of Contents)
Published: 2 Sep-2002
DOI: 10.3833/pdr.v2002.i28.1006 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Amsterdam Molecular Therapeutics (AMT) licensed the use of interleukin-10 (IL-10) under Schering-Plough’s extensive IL-10 patent portfolio for ex vivo gene therapy for gastrointestinal inflammatory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS